CYBN (Cybin Corp) Wutah bathi resik saben saham ing taun iki

Simbol resmi perusahaan Cybin (CYBN)

Cybin Inc. minimizes capital expenditures by outsourcing drug synthesis to external contractors. The distribution of the annual change in earnings per share confirms the financial trajectory, where 24.60 shows the current value of the metric. Potential revenue is expected from insurance reimbursements for depression therapy. The company is currently maximizing its research resources as it prepares to release innovative psilocybin-based molecules.

CYBN (cybin.com) riwayat Wutah bathi saben saham ing taun lumaku saka 04.07.2022 nganti 05.01.2026

Rincian metrik komprehensif lan analitis cybin.com (CYBN)

- nilai saham lan prakiraan konsensus rega:
Rega bursa Cybin|CYBN - Prakiraan konsensus analis
- indikator valuasi pasar bisnis:
Biji pasar Cybin Inc.|CYBN - Nilai Perusahaan
- rincian nilai buku perusahaan:
Nilai Akuntansi Saham Cybin|CYBN - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku cybin.com|CYBN - Total Aset Perusahaan
- indikator beban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Cybin Inc.|CYBN - Rasio utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Cybin|CYBN - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Cybin Inc.|CYBN - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Cybin|Rasio likuiditas darurat cybin.com
- indikator pendapatan resik lan kelipatan nilai:
CYBN - Penghasilan resik|Penghasilan resik sing dikarepake Cybin Inc.|CYBN - Pangali P/E|Kapitalisasi marang proyeksi bathi Cybin|CYBN - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi operasional sadurunge panyusutan Cybin Inc.|CYBN - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Cybin|CYBN - Bathi resik saben saham sajrone 12 wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan cybin.com|CYBN - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Cybin Inc.
Pambiji fundamental:Cybin Corp, CYBN
Barang utama Cybin Inc.

The long-term reliability of an issuer is determined by its ability to generate growing profits, which is reflected in the EPS YoY dynamics by calculating the percentage deviation of current earnings per share from the previous year's figures. For Cybin Inc. (CYBN), which is developing innovative psychedelic therapies for depression, this indicator serves as a marker for the transition from the R&D investment stage to the drug commercialization phase.

Pesaing langsung

Kacepetan wutah bathi saben saham ing taun lumaku Alkermes PLC (ALKS)|AVDL (Avadel Pharma) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki atai (ATAI)|Wutah bathi ing taun lumaku GHRS|MNMD (mindmed.co) - Tambahing bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku COMPASS Pathways CMPS|LB Pharmaceuticals, Inc. (LBRX) - Kacepetan wutah bathi saben saham ing taun lumaku|Bright Minds Biosciences Inc - Wutah bathi ing taun lumaku|Vanda (VNDA) - Wutah bathi resik saben saham ing taun iki|ANRO (Alto Neuroscience, Inc.) - Wutah bathi resik saben saham ing taun iki|Kacepetan wutah bathi saben saham ing taun lumaku nrxpharma.com (NRXP)|CING (Cingulate Inc) - Wutah bathi ing taun lumaku|Wutah bathi saben saham ing taun lumaku SILO|Wutah bathi ing taun lumaku CPHI|Prakiraan wutah bathi resik saben saham ing taun iki clearmindmedicine.com|Wutah bathi saben saham ing taun lumaku Psyence Biomedical Ltd. PBM|SPRC: Wutah bathi saben saham ing taun iki|SEEL: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku VRPX (Virpax Pharmaceuticals)|KRTX: Wutah bathi ing taun lumaku